By Michael Gwarisa Zimbabwe has been selected as one of 17 African countries to receive targeted support for mpox vaccine development, a major initiative spearheaded by the World Health Organization (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC). The initiative aims to bolster vaccine preparedness and deployment efforts across the continent,